CYP1A1 and neoplasm: Hence, the assays described, including CYP1A1 induction following incubation with unlabeled drug or induction of apoptosis, could be used with tumor biopsies or fine needle aspirates to select patients with the greater likelihood of benefit, while avoiding the toxicity of drug administration in patients who have a low likelihood of benefit from the agent.